StockData
TLRYNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends May 31

Tilray Brands, Inc.

Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026
$3.03−0.01 (-0.33%)

Close on Oct 19, 2026

Market cap
$404.02M
P/E (TTM)
–
Dividend yield
–

Earnings

Next report expected Jan 7, 2027, after market close (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q1 FY2027
Ended Aug 31, 2026
Oct 8, 2026Before market open$257.10M$-0.32$-0.02
Q4 FY2026
Ended May 31, 2026
Jul 28, 2026After market close$281.70M$-0.43$0.05
Q3 FY2026
Ended Feb 28, 2026
Apr 1, 2026Before market open$206.70M$-0.24$0.02
Q2 FY2026
Ended Nov 30, 2025
Jan 8, 2026After market close$217.50M$-0.41$-0.02
Q1 FY2026
Ended Aug 31, 2025
Oct 9, 2025Before market open$209.50M$0.00$0.00
Q4 FY2025
Ended May 31, 2025
Jul 28, 2025After market close$224.50M$-1.30$0.02
Q3 FY2025
Ended Feb 28, 2025
Apr 8, 2025Before market open$185.80M–$0.00
Q2 FY2025
Ended Nov 30, 2024
Jan 10, 2025Before market open$211.00M$-0.10$0.00
Q1 FY2025
Ended Aug 31, 2024
Oct 10, 2024Before market open–––
Q4 FY2024
Ended May 31, 2024
Jul 29, 2024After market close–––
Q3 FY2024
Ended Feb 29, 2024
Apr 9, 2024Before market open–––

Company guidance

Outlook given with results on Oct 8, 2026, compared with the previous outlook

MeasurePeriodGuidancevs. prior
adjusted EBITDAnon-GAAPFiscal Year 2027$68.00M to $75.00MMaintained

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements Tilray Brands filed with the SEC